Tag: pharmaceutical competition
- 18/Dec/2025
- by William Womack
-
antitrust laws
generic drugs
pay-for-delay
Hatch-Waxman Act
pharmaceutical competition
Antitrust Laws and Competition Issues in Generic Pharmaceutical Markets
Antitrust laws have driven down generic drug prices by up to 90%, but companies still use pay-for-delay deals, product hopping, and sham petitions to block competition. Learn how these tactics work and why they cost consumers billions.
Read
